about
A potential regulatory role for intronic microRNA-338-3p for its host gene encoding apoptosis-associated tyrosine kinaseTrimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypesDetermination of native oligomeric state and substrate specificity of rat NTPDase1 and NTPDase2 after heterologous expression in Xenopus oocytesTwo isoforms of the cold-inducible mRNA-binding protein RBM3 localize to dendrites and promote translationRegulation of axonal trafficking of cytochrome c oxidase IV mRNADisruption of the Axonal Trafficking of Tyrosine Hydroxylase mRNA Impairs Catecholamine Biosynthesis in the Axons of Sympathetic NeuronsThe fragile X mental retardation protein and group I metabotropic glutamate receptors regulate levels of mRNA granules in brain.Identification and quantitative analyses of microRNAs located in the distal axons of sympathetic neurons.Surface-localized glycine transporters 1 and 2 function as monomeric proteins in Xenopus oocytesP2X5 subunit assembly requires scaffolding by the second transmembrane domain and a conserved aspartate.MicroRNA networks direct neuronal development and plasticity.Unveiling the principle of microRNA-mediated redundancy in cellular pathway regulationConnecting Synaptic Activity with Plasticity-Related Gene Expression: From Molecular Mechanisms to Neurological Disorders.Monitoring mRNA Translation in Neuronal Processes Using Fluorescent Non-Canonical Amino Acid Tagging.The local expression and trafficking of tyrosine hydroxylase mRNA in the axons of sympathetic neuronsAn integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder.MicroRNAs in the axon and presynaptic nerve terminal.MicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression.MicroRNAs in Palatogenesis and Cleft Palate.Recent developments in optical neuromodulation technologies.microRNAs and the regulation of neuronal plasticity under stress conditions.Long non-coding RNAs in neurodevelopmental disorders.CK2-dependent C-terminal phosphorylation at T300 directs the nuclear transport of TSPY protein.Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability.Altered expression of circadian rhythm and extracellular matrix genes in the medial prefrontal cortex of a valproic acid rat model of autism.A heterogeneous population of nuclear-encoded mitochondrial mRNAs is present in the axons of primary sympathetic neuronsThe schizophrenia risk gene MIR137 acts as a hippocampal gene network node orchestrating the expression of genes relevant to nervous system development and function.Enhanced protein production by microRNA-30 family in CHO cells is mediated by the modulation of the ubiquitin pathway.A functional high-content miRNA screen identifies miR-30 family to boost recombinant protein production in CHO cells.Breaking limitations of complex culture media: functional non-viral miRNA delivery into pharmaceutical production cell lines.MicroRNA-137 regulates a glucocorticoid receptor-dependent signalling network: implications for the etiology of schizophrenia.MicroRNA-181 promotes synaptogenesis and attenuates axonal outgrowth in cortical neurons.Ceramide induces translocation of protein kinase C-alpha to the Golgi compartment of human embryonic kidney cells by interacting with the C2 domain.MicroRNA-338 Attenuates Cortical Neuronal Outgrowth by Modulating the Expression of Axon Guidance GenesAxonal localization and mitochondrial association of precursor microRNA 338.Nitric oxide induces degradation of the neutral ceramidase in rat renal mesangial cells and is counterregulated by protein kinase C.ATP potentiates interleukin-1 beta-induced MMP-9 expression in mesangial cells via recruitment of the ELAV protein HuR.High mitogenomic evolutionary rates and time dependency.MicroRNA-137 Controls AMPA-Receptor-Mediated Transmission and mGluR-Dependent LTD.Elevated microRNA-181c and microRNA-30d levels in the enlarged amygdala of the valproic acid rat model of autism.
P50
Q21090949-4CC62A1B-3C10-4F7E-8B57-448F5E1AD98DQ24301398-9B4920BE-25BD-4C1C-9257-FA2353587D48Q28571699-09F77FEB-DB50-46E9-A600-7E7330CA73CAQ28576423-7B079297-F9B0-45E3-B0C5-F360AF3DCD20Q33752081-8B4CEDCB-5472-4864-ACD8-AAFFF8432554Q33807402-94C1D18D-BFF6-4FBB-8955-418FF840C759Q33838422-A38D99CB-70C0-4433-A8E9-AD9904C39B9BQ34002197-8FF81733-9688-4138-90AD-56D7172028CCQ34082004-F7C96142-408C-4F26-AF47-F6E2809F5F4BQ34568867-B4C0704C-B590-4684-AFE6-DA4AF15587DDQ35644179-8471A18F-045E-4911-8486-3BD7FBCC1013Q36191693-F55E7613-4B26-4CE2-8AD5-57632A94F658Q36759628-710F3763-B052-48B5-8BB2-6707BE3A4A2CQ36852438-790C2CF4-8F2E-4E65-9646-393711E3C053Q36931474-C3E4CA45-0255-45DC-9F83-60CE343CE30CQ37026324-4F520960-DFD9-4535-B622-F37FE90F1677Q37072221-81CD37D2-395B-40EB-8846-EF4B12A3B1DDQ37227047-96EB214E-9609-404E-99F0-4562E66A86C4Q37736023-8CA6058B-E833-4C41-849A-C587EB1B36FBQ38052077-64AC7D3F-5868-4E9F-B9E8-E2EC3E393DC3Q38090271-4372C5A8-C899-4E85-A8ED-13CA0808B591Q38177786-8D6445BA-C0B5-4E46-9E6E-3522E6A758CAQ38316601-F27989CC-A232-4D1A-9E04-30BFB5E68E04Q38331099-5006FE02-8058-43CD-B6DB-7AF4BBF9ACA4Q38434827-B6EC13C9-F559-4888-86BA-9FFD511F75B9Q38445848-CDDA6F9A-5784-4C4A-A0A2-D1BD3A43238EQ38450466-9FC23934-D7A1-4D78-ABB4-4595BB57344DQ38845139-B9C12A7E-9FE2-4846-AC42-49DE7FEF5E55Q38971844-572B44E4-846C-468D-B331-5B01A6B593ACQ39102104-E0C02F90-C5A0-420C-AB03-CDFEC9850D17Q39185826-EDD9F7AA-D167-499E-BDE7-0AE60E13B65CQ39887252-0C402548-FA57-4925-9A58-FECA5B4620D4Q40625503-279B7549-9F29-44D7-B4EE-C98ECF56FC7BQ42618492-B2FF040F-AB58-4653-8CCE-DA6A060A2D59Q42682217-E83F6008-026F-4656-B621-8C8B82FD37D4Q44164565-1C914661-4A6A-453C-999A-33894EB1B26DQ44605213-AC4DDA4C-DBB6-4052-B99B-5C5FA84C3E28Q47434457-F8368AA6-6A75-44A0-8185-6A9830FF5BC1Q48118147-EF8CE62E-83C6-4901-9A20-38074B8092B8Q48171068-36CC2E1B-6732-49AE-B97D-4BCBE4ED4914
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Armaz Aschrafi
@ast
Armaz Aschrafi
@en
Armaz Aschrafi
@es
Armaz Aschrafi
@fr
Armaz Aschrafi
@nl
Armaz Aschrafi
@sl
type
label
Armaz Aschrafi
@ast
Armaz Aschrafi
@en
Armaz Aschrafi
@es
Armaz Aschrafi
@fr
Armaz Aschrafi
@nl
Armaz Aschrafi
@sl
prefLabel
Armaz Aschrafi
@ast
Armaz Aschrafi
@en
Armaz Aschrafi
@es
Armaz Aschrafi
@fr
Armaz Aschrafi
@nl
Armaz Aschrafi
@sl
P106
P31
P496
0000-0003-4089-0960